We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Methods Compared for Chagas Disease Diagnosis

By LabMedica International staff writers
Posted on 08 Aug 2017
Chagas Disease (CD) is a chronic infectious disease caused by the protozoan flagellate Trypanosoma cruzi. More...
In endemic countries, CD is transmitted mainly through the contact with feces of different triatomine bugs. Due to increased migration, CD has become an international health problem.

CD presents itself in two phases: whereas the acute phase is dominated by unspecific or no symptoms at all, in the chronic phase cardiac and/or gastrointestinal symptoms can occur after a long asymptomatic interval. Reliable diagnosis of chronically infected people is crucial for prevention of non-vectorial transmission as well as treatment.

European scientists led by those at the Medical Center of the University of Munich (Germany) tested samples consisting of 50 human EDTA blood samples that were previously tested positive by enzyme-linked immunosorbent assay (ELISA), immunofluorescence antibody test (IFAT) and polymerase chain reaction (PCR) for T. cruzi in the Instituto de Salud Carlos III, (Madrid, Spain) during 2010–2013. This study compared four distinct PCR methods for detection of T. cruzi DNA for the use in well-equipped routine diagnostic laboratories.

The team chose two conventional and two real-time PCR methods for closer evaluation. DNA was extracted of T. cruzi-positive and negative patients' blood samples and cultured T. cruzi, T. rangeli as well as Leishmania spp. One conventional and two real-time PCR methods targeting a repetitive satellite-DNA sequence as well as one conventional PCR method targeting the variable region of the kDNA minicircle were compared for sensitivity, intra- and interassay precision, limit of detection, specificity and cross-reactivity. For two methods the Professional Standard thermal cycler was operated, and for the other methods, the CFX C1000 Real-Time thermal cycler was used.

The team found that out of the 50 previously positive tested samples by serology and PCR, 44 samples were detected by all four methods. One method detected T. cruzi in all 50 samples. Potentially cross reactive agents (L. tropica, L. donovani, L. infantum, L. braziliensis, L. major, T. rangeli and T. brucei) showed similar results in all four methods. The costs of consumables are significantly cheaper for conventional methods than for real-time methods. The price of the conventional methods was below EUR 1/test, while it is around EUR two and eight per test for the relay time methods. The study was published in the July 2017 edition of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
Medical Center of the University of Munich
Instituto de Salud Carlos III


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Capillary testing on the Atellica analyzers supports the most common laboratory testing needs (Photo courtesy of Siemens Healthineers)

Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers

Venous blood draws can be challenging in patients with difficult veins, needle phobia, or limited blood volume, and they can slow collection in busy services. Core laboratories also face pressure to expand... Read more

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.